News All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute! Fulltext search Alphabetic A-Z Alphabetic Z-A Vall d’Hebron unveils a mural dedicated to female scientists The artwork Pioneres, presented on the International Day of Women and Girls in Science, is almost 40 metres long and portrays nine women, from Ancient Greece to the present day, who have contributed to the progress of sciences in the field of health. 11/02/2022 A project led by Laia Ventura, a Vall d'Hebron nurse, wins an award from the General Council of Nursing The work "Family presence during invasive procedures in pediatrics: perceptions, attitudes and practices of nurses" has received the Research Award of the General Council of Nursing in the category of Young Promises in Nursing Research. 09/02/2022 Colorectal cancers raise defensive barrier in response to chemotherapy Dr. Gerard Cantero, who is now a researcher at the CIBBIM-Nanomedicine - Kidney Physiopathology at VHIR, participated in the work led by CRG and IMIM. 08/02/2022 Vall d’Hebron renews its accreditation as a centre committed to excellence in nursing The recognition awards the Health Care Research Unit the prestigious RNAO and acknowledges the Hospital’s contribution and commitment to implementing the Best Practice Guidelines. 08/02/2022 Stable nanovesicles for the delivery of microRNA in cancer treatment It is first proof of concept for the delivery of a tumor-suppressive microRNA for the treatment of neuroblastoma, a highly-aggressive pediatric solid tumor of the peripheral nervous system. 04/02/2022 Precision medicine and innovation in research, protagonists at the World Cancer Day Conference The Vall d’Hebron Barcelona Hospital Campus has organised the World Cancer Day Conference as part of World Cancer Day, today, 4 February. 04/02/2022 Llistes de priorització de la Beca FI de l’AGAUR Ens plau comunicar que la Comissió Avaluadora Interna ha finalitzat el procés de valoració de les al·legacions presentades en relació a la priorització de persones candidates als Ajuts AGAUR FI-DGR 2022. 03/02/2022 Vall d’Hebron participates in RESPONSE, a global phase III clinical trial for the treatment of primary biliary cholangitis The innovative oral drug could provide a new therapeutic option for people with PBC who have not obtained the recommended therapeutic outcome or who do not tolerate first line therapy and cannot continue their treatment. 03/02/2022 Kern Pharma and Mi Compañero de Viaje donate €16,026 for research into paediatric sarcomas at Vall d’Hebron The donation will boost the research headed by Dr Josep Roma, researcher with the VHIR Childhood Cancer and Haematological Diseases group. 02/02/2022 Recruitment of volunteers starts for the Phase III clinical trial of the HIPRA COVID-19 vaccine The trial, which already has AEMPS authorisation, will be conducted in Spain, Portugal and Italy. 01/02/2022 The journal Nature publishes a review of severe COVID-19-related factors with the participation of Vall d’Hebron The publication summarises the main results showing that at least 20% of cases of severe pneumonia after SARS-CoV-2 infection are explained by genetic and immunological anomalies. 31/01/2022 A Vall d’Hebron study relates the impact of obesity to cognitive impairment The mechanisms in obesity that cause mild cognitive impairment are similar to those of type 2 diabetes. Fat is a powerful cerebral toxin and risk factor: it causes delayed reaction times in both executive function and attention. 26/01/2022 Researchers identify a molecule that could be involved in the formation of bone metastases in prostate cancer A group of researchers from Vall d’Hebron Research, IDIBELL and UB has identified a molecule involved in bone metastasis associated with prostate cancer that could be useful in the design of new therapies for its treatment. 25/01/2022 Vall d'Hebron identifies that patients with diabetes and myocardial insulin resistance have high cardiovascular risk Researchers have detected for the first time that people with type 2 diabetes who have insulin resistance in the myocardium have structural alterations of the heart and more calcifications in the coronary arteries that increase their risk of cardiovascular disease. 24/01/2022 The European RBDCOV project will study HIPRA’s COVID-19 vaccine in children, adolescents and immunocompromised patients Funded by the Horizon Europe programme, RBDCOV will test the efficacy, tolerability, and safety of the vaccine against the different variants of COVID-19 using a recombinant protein. 24/01/2022 A phase I clinical trial with Vall d'Hebron participation shows good results of a drug against childhood cancer Dr. Lucas Moreno and Dr. Constantino Sábado, researchers of the Translational Research Group in Childhood and Adolescent Cancer, are two of the leaders of the international study. 21/01/2022 A program to support patients with primary immunodeficiencies at Vall d'Hebron expands to Bellvitge Hospital The project "I have PID. I'm an adult and I'm not alone" offers telematic sessions to improve the emotional well-being of adult patients with this type of disease. 19/01/2022 New platform based on human lung tissue developed for SARS-CoV-2 study to help identify potential treatments The system can rapidly identify viral targets and the expression of viral entry factors, as well as detect inhibitors of viral entry into cells and anti-inflammatory compounds. 17/01/2022 The eye as a window onto the brain: retinal changes in diabetic patients could reflect the risk of cognitive impairment Identifying the common pathologies and molecular mechanisms involved in retinal and brain neurodegeneration could open up new opportunities in preventing type 2 diabetes-related cognitive impairment. 14/01/2022 The pre-enrollment for the 9th edition of Translational Biomedical Research Master at VHIR is now open The pre-enrollment period for the 2022-2023 academic year of the Master in Translational Biomedical Research at VHIR will be open from January 10 to September 5, 2022, or until all places are filled. 10/01/2022 Hakima Ouaarab, researcher at Vall d'Hebron, awarded by the journal Metas de Enfermería The project COCREA SASI. Co creation for the promotion of affective-sexual health from an intercultural perspective has won the award for Best Research Paper. 05/01/2022 Dr. Ferran Pellisé receives the Hibbs Award for research on spinal deviations The Scoliosis Research Society (SRS) has awarded with this prestigious recognition Dr. Pellisé's team for the study on the similarity of the adverse effects of surgeries both in elderly patients and in the general adult population. 05/01/2022 Vall d’Hebron tests the efficacy of a drug to treat neuroblastoma, a highly aggressive form of paediatric tumour The study shows the therapeutic effect of a new drug called 4SC-205 in new mouse neuroblastoma models, where it is effective in reducing the growth of the tumour. 04/01/2022 Vall d'Hebron, a reference in care and research in enterovirus infection This year, the Vall d'Hebron team has participated in the publication of three articles to understand the 2016 enterovirus A71 (EV-A71) outbreak in Catalonia and the follow-up of non-polio enteroviruses today. 29/12/2021 Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »